Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950103-25-006385·Legorreta Pablo G.
Schedule 13D ownership disclosure
ROYALTY PHARMA PLC- CL A
Class A ordinary shares, par value $0.0001 per share · CUSIP: G7709Q104
Event date: 2025-05-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Legorreta G. PabloReported CIK 0001507678
Shares: 103,112,796.00 · Class: 19.74%
- Legorreta Investments, LLC
Shares: 37,535,019.00 · Class: 8.14%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-25-006385
- Form type
- SCHEDULE 13D
- Filer
- Legorreta Pablo G.
- CIK
- CIK 1507678
- Filed
- May 23, 2025
- Reporting period
- May 16, 2025
- Description
- Schedule 13D beneficial ownership